January 2015 Drugs & Dealers Magazine Released
Biotech and Money are pleased to announce the release of the latest Drugs & Dealers Magazine. The January issue is the first of 6 bi-monthly publications in 2015 aimed at providing insight, foresight and hindsight to life science executives involved in funding, investment, partnering and deal making.
Here’s what you can expect to read from the digitally interactive January issue:
GLOBAL BIOTECH AND THE NEW INNOVATION CYCLE - David Pinniger, Fund Manager, Polar Capital Biotechnology Fund
R&D ALLIANCE, LICENSE AGREEMENTS AND BMC FUNDING - Dr Sam Williams, CEO, Modern Biosciences
CRT’S STATESIDE LICENSING AND PARTNERING ACTIVITY - Dr Larry Steranka, Managing Director, CRT Inc.
KILLER EXPERIMENTS AND KEYS TO A SUCCESSFUL DEAL - Kevin Johnson, Partner, Index Ventures
ASSETS, EXITS AND EXTERNALISATION - Jean Francois Formela, Partner, Atles Venture
‘BIOTECHS AND THE CITY’ LICENSING & PARTNERSHIPS - F-Star, GSK, Trimunocor, ex-Shire and Cell Therapy Ltd.
PRESENTING SCIENTIFIC LEADERSHIP AND A CLEAR FOCUS - Shaun Grady, VP, BD Operations, AstraZeneca
BIOTECH AND MONEY LONDON 2015 - Event details
KEEPING PACE WITH A CHANGING HEALTHCARE LANDSCAPE - Chris Stirling, Global Head of Life Sciences, KPMG
21ST CENTURY FUNDING FOR 21ST CENTURY MEDICINES - Crowdcube, Cell Therapy Ltd. and KPMG
COUNTING ON BIOTECH - Sue Staunton, Partner, James Cowper
Plus regular pieces ‘IN BRIEF’ - on recent announcements in the funding and investment landscape and ‘SAVE THE DATE’ - outlining up and coming key UK awards and grant competition deadlines.